Pancreatic cancer among solid organ transplant recipients in the United States
- PMID: 35932302
- PMCID: PMC11797600
- DOI: 10.1007/s00432-022-04227-3
Pancreatic cancer among solid organ transplant recipients in the United States
Abstract
Introduction: Pancreatic cancer (PC) in solid organ transplant (SOT) recipients is not well studied. Some PC cases may be incidentally detected during hepatobiliary imaging.
Methods: We evaluated PC among 374,106 SOT recipients during 1995-2017 in the United States using linked data from the national transplant registry and multiple state/regional cancer registries. Standardized incidence ratios (SIRs) were used to compare PC risk in recipients to the general population. We used multivariate Poisson regression to identify independent risk factors for PC. We assessed survival after PC diagnosis using Kaplan-Meier curves and log-rank tests.
Results: SOT recipients had elevated incidence for PC compared with the general population (SIR 1.40, 95% CI 1.29-1.52), and this increase was strongest in liver recipients (1.65, 1.41-1.92). Among all recipients, PC incidence was especially increased for cases arising in the head of the pancreas (SIR 1.50, 95% CI 1.34-1.68) and for cases diagnosed at localized stage (1.85, 1.37-2.44). Among SOT recipients, factors independently associated with increased incidence were consistent with those in general population including male sex, older age, non-O blood type, and history of diabetes. Additionally, compared to other organ recipients, liver transplant recipients had higher PC incidence (adjusted incidence rate ratio 1.28; 95% CI 1.06-1.54). Overall survival after PC diagnosis was poor (median 4 months) and similar between liver and other organ transplant recipients (p = 0.08).
Conclusions: PC incidence is elevated among SOT recipients, and more commonly diagnosed in liver transplant recipients perhaps related to incidental detection. However, survival is poor even in liver recipients, arguing against routine PC screening.
Keywords: Cancer epidemiology; Pancreatic cancer; Solid organ transplantation.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Gastroenterology.
Figures


References
-
- Anis KH, Weinrauch LA, D’Elia JA (2019) Effects of smoking on solid organ transplantation outcomes. Am J Med 132:413–419 - PubMed
-
- Collett D, Mumford L, Banner NR, Neuberger J, Watson C (2010) Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 10:1889–1896 - PubMed
-
- Corral JE, Croome KP, Keaveny AP et al (2021) A 3-decade analysis of pancreatic adenocarcinoma after solid organ transplant. Pancreas 50:54–63 - PubMed
MeSH terms
Grants and funding
- 75N96021D00006/ES/NIEHS NIH HHS/United States
- HHSN261201000036C/CA/NCI NIH HHS/United States
- HHSN261201800013C/CA/NCI NIH HHS/United States
- N01 PC035137/CA/NCI NIH HHS/United States
- U58 DP000807/DP/NCCDPHP CDC HHS/United States
- N01 PC035142/CA/NCI NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- U58 DP000848/DP/NCCDPHP CDC HHS/United States
- 75N92021D00009/HL/NHLBI NIH HHS/United States
- HHSN261201800002B/CA/NCI NIH HHS/United States
- 75N98021D00006/OD/NIH HHS/United States
- HHSN261201000037C/CA/NCI NIH HHS/United States
- U58 DP003883/DP/NCCDPHP CDC HHS/United States
- N01 PC035143/CA/NCI NIH HHS/United States
- HHSN261201000035C/CA/NCI NIH HHS/United States
- U58 DP003875/DP/NCCDPHP CDC HHS/United States
- 75N97021D00006/LM/NLM NIH HHS/United States
- HHSN261201800014C/CA/NCI NIH HHS/United States
- HHSN261201800016C/CA/NCI NIH HHS/United States
- N01 PC035139/CA/NCI NIH HHS/United States
- 75N99021D00009/OF/ORFDO NIH HHS/United States
- HHSN261201800016I/CA/NCI NIH HHS/United States
- U58 DP003933/DP/NCCDPHP CDC HHS/United States
- 75N90021D00009/CL/CLC NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- U58 DP003921/DP/NCCDPHP CDC HHS/United States
- 75N92021D00006/HL/NHLBI NIH HHS/United States
- HHSN261201800014I/CA/NCI NIH HHS/United States
- 75N96021D00009/ES/NIEHS NIH HHS/United States
- HHSN261201800002C/CA/NCI NIH HHS/United States
- HHSN261201800013I/CA/NCI NIH HHS/United States
- HHSN261201800006I/CA/NCI NIH HHS/United States
- U58 DP000824/DP/NCCDPHP CDC HHS/United States
LinkOut - more resources
Full Text Sources
Medical